title: Gastrointestinal lymphoma.
abstract: Primary GI lymphoma is a rare clinical entity. A primary nodal tumor should be ruled out. Symptoms may not be localizing and B symptoms are less common. A tissue diagnosis, preferably by transmural biopsy for small intestinal involvement, often reveals a high-grade morphology. The staging work-up should include a bone marrow examination, although formal staging laparatomy is not always required. Patients with Mushoff stage IE or IIE1 disease do better than those with extraregional nodal disease or distant metastatic involvement. Surgical resection with clear margins is required in order to maximize the changes for cure. Chemotherapy or radiotherapy may give a survival advantage when used as adjuvant treatment for selected stage IE and IIE disease. Chemotherapy should be used after surgical debulking in more advanced disease in order to minimize the chance for bleeding or performation. Future randomized, multi-institutional trials will give more direction as to the best modes of management.
authors.affiliation: Department of Internal Medicine, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.
authors.forename: C R
authors.initials: CR
authors.lastname: Thomas
authors.forename: R
authors.initials: R
authors.lastname: Share
mesh_terms: D000368:Aged; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy; D006801:Humans; D007161:Immunoproliferative Small Intestinal Disease / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008113:Liver Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008223:Lymphoma / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy; D008297:Male; D011379:Prognosis